Target intelligence / Profile preview

Ferritin heavy chain 1 pseudogene 23 (FTH1P23)

Target
FTH1P23
Molecular classification
Pseudogene, Processed pseudogene, Long non-coding RNA (lncRNA)
01

Overview

Ferritin heavy chain 1 pseudogene 23 (FTH1P23) is a **processed pseudogene**, meaning it is a non-functional copy of the ferritin heavy chain 1 (FTH1) gene[1][9]. Although originally annotated as a pseudogene, studies have shown that similar pseudogenes such as FTH1P3 are **transcriptionally active** and may be **widely expressed in human tissues**, functioning at the RNA level rather than encoding a protein[7][9]. Like other ferritin heavy chain pseudogenes, FTH1P23 may possess **regulatory roles**, potentially affecting the expression and translation of the functional FTH1 gene via molecular mechanisms involving microRNAs (miRNAs) or RNA-binding proteins, especially given the presence of conserved iron-responsive element (IRE) sequences in the untranslated regions of these transcripts[7][9]. However, there is no evidence that FTH1P23 directly encodes a functional protein or serves as a typical drug target, receptor, enzyme, or transporter in therapeutic development[1][9]. Its biological roles are mainly speculative and relate to gene regulation within the ferritin gene family network rather than direct physiological or pharmacological functions.

Other names
FTH1 pseudogene 23FTH1P23Ferritin heavy polypeptide 1 pseudogene 23
02

Biological functions

Possible regulation of parental gene expression through competitive endogenous RNA (ceRNA) activity or RNA-binding protein sequestration
03

Disease associations

Insufficient evidence for direct involvement in any specific disease, though ferritin gene family has regulatory associations with cancer and cell metabolism

Beyond the preview

Go deeper on Ferritin heavy chain 1 pseudogene 23 (FTH1P23).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ferritin heavy chain 1 pseudogene 23 (FTH1P23).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call